Search research articles
Contact Us
Filters
Showing results (151-160 of 293) with videos related to
Page
of 30
Sort By:
Oncogene
|
July 31, 2021
Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss
Shuning He, Mark W Zimmerman, Hillary M Layden, et al.
Journal for Immunotherapy of Cancer
|
November 13, 2021
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial
Patrick A Ott, Matthew Nazzaro, Kathleen L Pfaff, et al.
The Journal of Clinical Investigation
|
November 2, 2012
Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus
Scott J Rodig, Jingwei Cheng, Jacek Wardzala, et al.
JCO Precision Oncology
|
February 8, 2024
Association of Baseline Tumor-Specific Neoantigens and CD8<sup>+</sup> T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, et al.
Cancer Cell
|
March 24, 2012
Activated ALK collaborates with MYCN in neuroblastoma pathogenesis
Shizhen Zhu, Jeong-Soo Lee, Feng Guo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 24, 2011
The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo
Jun Yang, Leonardo V Riella, Susanne Chock, et al.
Diabetes
|
September 1, 2010
A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice
Andrea Vergani, Francesca D'Addio, Mollie Jurewicz, et al.
Cell Reports. Medicine
|
October 15, 2025
Pan-cancer spatial characterization of key immune biomarkers in the tumor microenvironment
James R Lindsay, Jennifer Altreuter, Joao V Alessi, et al.
Cancer
|
April 26, 2017
Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study
Eytan Ben-Ami, Constance M Barysauskas, Sarah Solomon, et al.
Immunity
|
February 24, 2017
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
Suzanne George, Diana Miao, George D Demetri, et al.
Page
of 30
Search research articles
Search
Showing results (151-160 of 293) with videos related to
Sort By:
Page
of 30
Oncogene
|
July 31, 2021
Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss
Shuning He, Mark W Zimmerman, Hillary M Layden, et al.
Journal for Immunotherapy of Cancer
|
November 13, 2021
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial
Patrick A Ott, Matthew Nazzaro, Kathleen L Pfaff, et al.
The Journal of Clinical Investigation
|
November 2, 2012
Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus
Scott J Rodig, Jingwei Cheng, Jacek Wardzala, et al.
JCO Precision Oncology
|
February 8, 2024
Association of Baseline Tumor-Specific Neoantigens and CD8<sup>+</sup> T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, et al.
Cancer Cell
|
March 24, 2012
Activated ALK collaborates with MYCN in neuroblastoma pathogenesis
Shizhen Zhu, Jeong-Soo Lee, Feng Guo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 24, 2011
The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo
Jun Yang, Leonardo V Riella, Susanne Chock, et al.
Diabetes
|
September 1, 2010
A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice
Andrea Vergani, Francesca D'Addio, Mollie Jurewicz, et al.
Cell Reports. Medicine
|
October 15, 2025
Pan-cancer spatial characterization of key immune biomarkers in the tumor microenvironment
James R Lindsay, Jennifer Altreuter, Joao V Alessi, et al.
Cancer
|
April 26, 2017
Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study
Eytan Ben-Ami, Constance M Barysauskas, Sarah Solomon, et al.
Immunity
|
February 24, 2017
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
Suzanne George, Diana Miao, George D Demetri, et al.
Page
of 30